For the quarter ended June 2026, Procter & Gamble (PG) reported revenue of $21.2 billion, up 1.5% over the same period last year. EPS came in at $1.43, compared to $1.48 in the year-ago quarter.
The reported revenue compares to the Zacks Consensus Estimate of $21.36 billion, representing a surprise of -0.73%. The company delivered an EPS surprise of +1.42%, with the consensus EPS estimate being $1.41.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how P&G performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Organic Sales Growth (YoY change) - Beauty: 4% versus the five-analyst average estimate of 3.2%. Organic Sales Growth (YoY change) - Baby, Feminine & Family Care: -2% compared to the 0.3% average estimate based on five analysts. Organic Sales Growth (YoY change) - Health Care: -1% versus the five-analyst average estimate of 1.3%. Net Sales- Beauty: $3.98 billion versus $3.88 billion estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +6.5% change. Net Sales- Grooming: $1.7 billion versus $1.71 billion estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +1% change. Net Sales- Corporate: $292 million versus the six-analyst average estimate of $250.59 million. The reported number represents a year-over-year change of +6.6%. Net Sales- Fabric & Home Care: $7.43 billion versus the six-analyst average estimate of $7.51 billion. The reported number represents a year-over-year change of +0.6%. Net Sales- Baby, Feminine & Family Care: $5.05 billion versus the six-analyst average estimate of $5.12 billion. The reported number represents a year-over-year change of -0.9%. Net Sales- Health Care: $2.76 billion compared to the $2.79 billion average estimate based on six analysts. The reported number represents a change of +1.3% year over year. Earnings before income taxes- Beauty: $588 million versus the three-analyst average estimate of $714.12 million. Earnings before income taxes- Grooming: $414 million versus $446.33 million estimated by three analysts on average. Earnings before income taxes- Health Care: $449 million compared to the $477.62 million average estimate based on three analysts.View all Key Company Metrics for P&G here>>>
Shares of P&G have returned +1.5% over the past month versus the Zacks S&P 500 composite's +1.9% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.Zacks' Research Chief Names "Stock Most Likely to Double"
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.
This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.
Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Procter & Gamble Company (The) (PG): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).